Seronegative autoimmune encephalitis: clinical characteristics and factors associated with outcomes

医学 自身免疫性脑炎 美罗华 免疫疗法 改良兰金量表 脑炎 内科学 免疫学 抗体 免疫系统 病毒 缺血 缺血性中风
作者
Woojin Lee,Han-Sang Lee,Do-Yong Kim,Hye-Sung Lee,Jangsup Moon,Kyung‐Il Park,Sang Kun Lee,Kon Chu
出处
期刊:Brain [Oxford University Press]
卷期号:145 (10): 3509-3521 被引量:18
标识
DOI:10.1093/brain/awac166
摘要

Abstract Seronegative autoimmune encephalitis is autoimmune encephalitis without any identifiable pathogenic antibody. Although it is a major subtype of autoimmune encephalitis, many unmet clinical needs exist in terms of clinical characteristics, treatments and prognosis. In this institutional cohort study, patients diagnosed with seronegative autoimmune encephalitis with available 2-year outcomes were analysed for the disease course, 2-year outcome prediction system, effect of immunotherapy, necessity of further immunotherapy at 6 or 12 months and pattern of brain atrophy. Seronegative autoimmune encephalitis was subcategorized into antibody-negative probable autoimmune encephalitis, autoimmune limbic encephalitis and acute disseminated encephalomyelitis. Poor 2-year outcome was defined by modified Rankin scale scores 3–6, and the 2-year serial data of Clinical Assessment Scales in Autoimmune Encephalitis score was used for longitudinal data analyses. A total of 147 patients were included. The frequency of achieving a good 2-year outcome (modified Rankin scale 0–2) was 56.5%. The antibody-negative probable autoimmune encephalitis subtype exhibited the poorest outcomes, although the baseline severity was similar among the subtypes. The RAPID score, consisting of five early usable clinical factors, refractory status epilepticus, age of onset ≥60 years, probable autoimmune encephalitis (antibody-negative probable autoimmune encephalitis subtype), infratentorial involvement and delay of immunotherapy ≥1 month, was associated with poorer 2-year outcomes. Any immunotherapy was associated with clinical improvement in the patients with low risk for poor 2-year outcomes (RAPID scores 0–1), and the combination immunotherapy of steroid, immunoglobulin, rituximab and tocilizumab was associated with better outcomes in the patients with high risk for poor 2-year outcomes (RAPID scores 2–5). In patients with persistent disease at 6 months, continuing immunotherapy was associated with more improvement, while the effect of continuing immunotherapy for more than 12 months was unclear. In the longitudinal analysis of MRI, the development of cerebellar atrophy indicated poor outcomes, while the absence of diffuse cerebral atrophy or medial temporal atrophy indicated the possibility of a good outcome. This study provides information about the clinical characteristics and courses, the effect of immunotherapy and its duration, and prognostic factors in seronegative autoimmune encephalitis.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
毕威发布了新的文献求助10
4秒前
5秒前
8秒前
9秒前
得鹿梦鱼完成签到,获得积分10
9秒前
星辰大海应助害羞的败采纳,获得10
12秒前
羊1U发布了新的文献求助10
12秒前
阿亮86完成签到,获得积分10
16秒前
虎虎虎完成签到,获得积分10
17秒前
免疫方舟完成签到,获得积分0
18秒前
19秒前
23秒前
新手完成签到,获得积分10
25秒前
林宥嘉应助科研通管家采纳,获得10
25秒前
25秒前
星辰大海应助科研通管家采纳,获得10
25秒前
25秒前
SciGPT应助科研通管家采纳,获得10
25秒前
26秒前
真好发布了新的文献求助10
27秒前
大方大船发布了新的文献求助10
28秒前
黄维发布了新的文献求助10
31秒前
32秒前
向阳葵完成签到 ,获得积分10
33秒前
Lyn完成签到 ,获得积分10
35秒前
gj完成签到 ,获得积分10
38秒前
望山云雾完成签到,获得积分10
38秒前
Hehehe发布了新的文献求助10
38秒前
ding应助wtt采纳,获得10
39秒前
39秒前
NADA完成签到,获得积分10
39秒前
42秒前
44秒前
44秒前
孤独秋烟完成签到 ,获得积分10
46秒前
47秒前
Dou发布了新的文献求助10
49秒前
科研糊涂神完成签到,获得积分10
52秒前
wangjingli666应助kkkkk采纳,获得10
55秒前
科目三应助ID27149采纳,获得10
56秒前
高分求助中
请在求助之前详细阅读求助说明!!!! 20000
The Three Stars Each: The Astrolabes and Related Texts 900
Yuwu Song, Biographical Dictionary of the People's Republic of China 700
Multifunctional Agriculture, A New Paradigm for European Agriculture and Rural Development 600
Bernd Ziesemer - Maos deutscher Topagent: Wie China die Bundesrepublik eroberte 500
A radiographic standard of reference for the growing knee 400
Glossary of Geology 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 有机化学 工程类 生物化学 纳米技术 物理 内科学 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 电极 光电子学 量子力学
热门帖子
关注 科研通微信公众号,转发送积分 2474707
求助须知:如何正确求助?哪些是违规求助? 2139649
关于积分的说明 5452819
捐赠科研通 1863310
什么是DOI,文献DOI怎么找? 926369
版权声明 562840
科研通“疑难数据库(出版商)”最低求助积分说明 495538